JPRN-UMIN000004682已完成1 期
Phase I study of GEM or S-1 adjuvant therapy after hemihepatectomy for biliary tract cancer (KHBO1003) - Phase I study of GEM or S-1 adjuvant therapy after hemihepatectomy for biliary tract cancer (KHBO1003)
Kansai Hepatobiliary Oncology Group (KHBO)0 个研究点目标入组 6 人开始时间: 2010年12月10日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 6
研究概览
简要总结
Cancer Chemother Pharmacol. 2014 Oct;74(4):699-709
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Active double cancer 2) Severe drug allergy 3) Severe complications (IP, HF, RF, LF, ileus, DM, etc) 4) Active infections 5) Pregnancy 6) Severe mental disorder 7) Others
研究者
相似试验
招募中
不适用
eoadjuvant chemoradiotherapy of GEM +S-1 for resectable pancreatic cancer : Phase II studyPancreatic cancerJPRN-UMIN000032361Yokohama City University School of Medicine Department of Gastroenterological Surgery50
招募中
不适用
A Phase I study of adjuvant chemotherapy with gemcitabine plus S-1 in patients with biliary tract cancer undergoing curative resection without major hepatectomyBiliary tract cancer undergoing curative resection without major hepatectomyJPRN-UMIN000007454Kansai Hepatobiliary Oncology Group (KHBO)24
已完成
不适用
A Phase I study of adjuvant chemotherapy with gemcitabine plus cisplatin in patients with biliary tract cancer undergoing curative resection without major hepatectomyBiliary tract cancer undergoing curative resection without major hepatectomyJPRN-UMIN000004622Kansai Hepatobiliary Oncology Group (KHBO)24
已完成
1 期
A Phase I Study of Adjuvant Chemotherapy With GS in Biliary Tract Cancer Undergoing Resection Without Major HepatectomyBiliary Tract CancerNCT01713387Kansai Hepatobiliary Oncology Group38
已完成
不适用
Phase II study of adjuvant chemotherapy with gemcitabine and regional arterial infusion of nafamostat mesilate for the patients with resectable pancreatic cancerJPRN-UMIN000006163Jikei University school of Medicine30